A combination of low-dose bevacizumab and imatinib enhances vascular normalisation without inducing extracellular matrix deposition
低剂量贝伐单抗和伊马替尼联合使用可增强血管正常化，而不会诱导细胞外基质沉积
期刊:British Journal of Cancer
影响因子:6.4
doi:10.1038/bjc.2017.13
L M Schiffmann, M Brunold, M Liwschitz, V Goede, S Loges, M Wroblewski, A Quaas, H Alakus, D Stippel, C J Bruns, M Hallek, H Kashkar, U T Hacker, O Coutelle
